New appointments to AAO

Article

Dennis S.C. Lam, MD, of Hong Kong and Stefan Seregard, MD, of Sweden have been appointed to serve a one-year term on the American Academy of Ophthalmology's (AAO) Board of Trustees.

Dennis S.C. Lam, MD, of Hong Kong and Stefan Seregard, MD, of Sweden have been appointed to serve a one-year term on the American Academy of Ophthalmology's (AAO) Board of Trustees.

The International Advisor position on the AAO Board was established in 2010 to bring a global perspective to the board's decision making and policy setting. Each advisor serves a one-year term and represents one of the five major geographic world regions. In 2011, the new appointees will represent two of the remaining three regions.

“The AAO has a substantial number of international members,” said David W. Parke II, MD, executive vice president and CEO of the AAO. “At the same time, we have expanded upon and strengthened our relationships with national and supranational ophthalmic societies worldwide. We are very fortunate to add the insight of strong leaders like Dr Lam and Dr Seregard to our board of trustees and will look to them for guidance regarding our participation in the international ophthalmic community.”

Dr Lam is the chairman of the department of ophthalmology and visual sciences at the Chinese University of Hong Kong. He is the secretary-general and CEO of the Asia-Pacific Academy of Ophthalmology (APAO), and served as president and organizing committee chairman of the 2008 World Ophthalmology Congress (held in Hong Kong).

Dr Seregard is professor of ophthalmology, Karolinska Institutet, and chairman, department of vitreoretinal diseases, at St. Erik's Eye Hospital in Stockholm. He currently serves as secretary general of the European Ophthalmological Society and president of the Swedish Ophthalmological Society.

Source: American Academy of Ophthalmology

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.